Suchergebnisse - (Person:"Gökmen-Polar, Yesim")

PubPharm (7)

1

A predictor of response in HER2+ breast cancer-at last!

enthalten in: Journal of the National Cancer Institute | 2023

von Badve, S. | Gökmen-Polar, Y.

CommentOn: J Natl Cancer Inst. 2023 Mar 9;115(3):332-336. - PMID 36576009

2

TP53 Status and Estrogen Receptor-Beta in Triple-Negative Breast Cancer : Company Matters

enthalten in: Journal of the National Cancer Institute | 2019

von Badve, S. | Gökmen-Polar, Y.

CommentOn: J Natl Cancer Inst. 2019 Nov 1;111(11):1202-1215. - PMID 30990221

3

EarlyR : A Robust Gene Expression Signature for Predicting Outcomes of Estrogen Receptor-Positive Breast Cancer

enthalten in: Clinical breast cancer | 2019

von Buechler, S. | Gökmen-Polar, Y. | Badve, S.

4

Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients

enthalten in: Journal of neuro-oncology | 2015

von Duchnowska, R. | Jassem, J. | Goswami, C. | +14

5

Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers

enthalten in: Scientific reports | 2015

von Gökmen-Polar, Y. | Vladislav, I. | Neelamraju, Y. | +2

6

Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer

enthalten in: Breast cancer research and treatment | 2011

von Gökmen-Polar, Y. | Toroni, R. | Hocevar, B. | +6

7

Differential subcellular expression of protein kinase C betaII in breast cancer : correlation with breast cancer subtypes

enthalten in: Breast cancer research and treatment | 2010

von Gökmen-Polar, Y. | Mehta, R. | Tuzmen, S. | +8

1
[1]